Search Results - Wei, Yongqiang, PhD

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    Nilotinib for imatinib-resistant or -intolerant chronic myeloid leukemia in chronic phase, accelerated phase, or blast crisis: A single- and multiple-dose, open-label pharmacokinetic study in Chinese patients

    Nilotinib for imatinib-resistant or -intolerant chronic myeloid leukemia in chronic phase, accelerated phase, or blast crisis: A single- and multiple-dose, open-label pharmacokinet... by Zhou, Li, PhD, Meng, Fanyi, MD, Yin, Ophelia, PhD, Wang, Jianxiang, PhD, Wang, Ying, PhD, Wei, Yongqiang, PhD, Hu, Pei, PhD, Shen, Zhixiang, MD

    Published in Clinical therapeutics
    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: